Coco Publishes 2025 Annual Report and 2026 Q1 Report

 Hangzhou Coco Healthcare Products Co., Ltd. achieved operating revenue of approximately RMB 1.150 billion in 2025, representing a year-on-year increase of 6.65%. Net profit attributable to shareholders of the listed company was approximately RMB 36.1187 million, up 15.87% year-on-year. In the first quarter of 2026, operating revenue was approximately RMB 291 million, up 3.97% year-on-year. Net profit attributable to shareholders of the listed company was approximately RMB 1.8798 million, down 89.89% year-on-year.